These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 12228207

  • 1. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
    Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, Neumann HJ, Mlineritsch B, DeSantis M, Quehenberger F, Chott A, Beham-Schmid C, Höfler G, Linkesch W, Raderer M.
    J Clin Oncol; 2002 Sep 15; 20(18):3872-7. PubMed ID: 12228207
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME, Raderer M.
    Hematol Oncol; 2017 Jun 15; 35(2):177-186. PubMed ID: 26580149
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine.
    Valencak J, Trautinger F, Fiebiger WC, Raderer M.
    Ann Hematol; 2002 Nov 15; 81(11):662-5. PubMed ID: 12454707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
    Kiesewetter B, Mayerhoefer ME, Lukas J, Zielinski CC, Müllauer L, Raderer M.
    Ann Hematol; 2014 Feb 15; 93(2):249-53. PubMed ID: 23925930
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
    Troch M, Kiesewetter B, Willenbacher W, Willenbacher E, Zebisch A, Linkesch W, Fridrik M, Müllauer L, Greil R, Raderer M.
    Haematologica; 2013 Feb 15; 98(2):264-8. PubMed ID: 22983582
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.
    Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F, Delchier JC.
    J Clin Oncol; 1995 Oct 15; 13(10):2524-9. PubMed ID: 7595703
    [Abstract] [Full Text] [Related]

  • 11. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
    Raderer M, Jäger G, Brugger S, Püspök A, Fiebiger W, Drach J, Wotherspoon A, Chott A.
    Oncology; 2003 Oct 15; 65(4):306-10. PubMed ID: 14707449
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma.
    Raderer M, Wöhrer S, Bartsch R, Prager G, Drach J, Hejna M, Gaiger A, Turetschek K, Jaeger U, Streubel B, Zielinski CC.
    J Clin Oncol; 2005 Nov 20; 23(33):8442-6. PubMed ID: 16293875
    [Abstract] [Full Text] [Related]

  • 13. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
    Wöhrer S, Drach J, Hejna M, Scheithauer W, Dirisamer A, Püspök A, Chott A, Raderer M.
    Ann Oncol; 2003 Dec 20; 14(12):1758-61. PubMed ID: 14630681
    [Abstract] [Full Text] [Related]

  • 14. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
    Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Patterson BJ.
    J Clin Oncol; 2003 Nov 15; 21(22):4157-64. PubMed ID: 14615444
    [Abstract] [Full Text] [Related]

  • 15. Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
    Conconi A, Raderer M, Franceschetti S, Devizzi L, Ferreri AJ, Magagnoli M, Arcaini L, Zinzani PL, Martinelli G, Vitolo U, Kiesewetter B, Porro E, Stathis A, Gaidano G, Cavalli F, Zucca E.
    Br J Haematol; 2014 Jul 15; 166(1):69-76. PubMed ID: 24673512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 20. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C.
    Haematologica; 2001 Jun 21; 86(6):609-17. PubMed ID: 11418369
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.